Literature DB >> 21631540

Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol.

Lara S Hwa1, Adam Chu, Sally A Levinson, Tala M Kayyali, Joseph F DeBold, Klaus A Miczek.   

Abstract

BACKGROUND: Intermittent access (IA) to drugs of abuse, as opposed to continuous access, is hypothesized to induce a kindling-type transition from moderate to escalated use, leading to dependence. Intermittent 24-hour cycles of ethanol access and deprivation can generate high levels of voluntary ethanol drinking in rats.
METHODS: The current study uses C57BL/6J mice (B6) in an IA to 20% ethanol protocol to escalate ethanol drinking levels. Adult male and female B6 mice were given IA to 20% ethanol on alternating days of the week with water available ad libitum. Ethanol consumption during the initial 2 hours of access was compared with a short-term, limited access "binge" drinking procedure, similar to drinking-in-the-dark (DID). B6 mice were also assessed for ethanol dependence with handling-induced convulsion, a reliable measure of withdrawal severity.
RESULTS: After 3 weeks, male mice given IA to ethanol achieved high stable levels of ethanol drinking in excess of 20 g/kg/24 h, reaching above 100 mg/dl blood ethanol concentrations, and showed a significantly higher ethanol preference than mice given continuous access to ethanol. Also, mice given IA drank about twice as much as DID mice in the initial 2-hour access period. B6 mice that underwent the IA protocol for longer periods of time displayed more severe signs of alcohol withdrawal. Additionally, female B6 mice were given IA to ethanol and drank significantly more than males (ca. 30 g/kg/24 h). DISCUSSION: The IA method in B6 mice is advantageous because it induces escalated, voluntary, and preferential per os ethanol intake, behavior that may mimic a cardinal feature of human alcohol dependence, though the exact nature and site of ethanol acting in the brain and blood as a result of IA has yet to be determined.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631540      PMCID: PMC3166538          DOI: 10.1111/j.1530-0277.2011.01545.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  73 in total

1.  Persistence of a "subacute withdrawal syndrome" following chronic ethanol intake.

Authors:  H Begleiter; B Porjesz
Journal:  Drug Alcohol Depend       Date:  1979 May-Jul       Impact factor: 4.492

2.  Development of an alcohol deprivation and escalation effect in C57BL/6J mice.

Authors:  Roberto I Melendez; Lawrence D Middaugh; Peter W Kalivas
Journal:  Alcohol Clin Exp Res       Date:  2006-12       Impact factor: 3.455

3.  Toward an analogue of alcoholism in mice: criteria for recognition of pharmacologically motivated drinking.

Authors:  V P Dole; A Ho; R T Gentry
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Development of an alcohol-deprivation effect in rats.

Authors:  J D Sinclair; R J Senter
Journal:  Q J Stud Alcohol       Date:  1968-12

5.  Excessive ethanol drinking following a history of dependence: animal model of allostasis.

Authors:  A J Roberts; C J Heyser; M Cole; P Griffin; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-06       Impact factor: 7.853

6.  Mouse inbred strain differences in ethanol drinking to intoxication.

Authors:  J S Rhodes; M M Ford; C-H Yu; L L Brown; D A Finn; T Garland; J C Crabbe
Journal:  Genes Brain Behav       Date:  2007-02       Impact factor: 3.449

Review 7.  Sex differences in the central nervous system actions of ethanol.

Authors:  Leslie L Devaud; Paul Alele; Chadda Ritu
Journal:  Crit Rev Neurobiol       Date:  2003

8.  Time-dependent quantifiable withdrawal from ethanol in the rat: effect of method of dependence induction.

Authors:  D J Macey; G Schulteis; S C Heinrichs; G F Koob
Journal:  Alcohol       Date:  1996 Mar-Apr       Impact factor: 2.405

9.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

10.  Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure.

Authors:  Laura E O'Dell; Amanda J Roberts; Ron T Smith; George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2004-11       Impact factor: 3.455

View more
  142 in total

1.  Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.

Authors:  Yan Zhou; Rachel Saylor Crowley; Konrad Ben; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2017-03-02       Impact factor: 3.252

Review 2.  The neurobiology of binge-like ethanol drinking: evidence from rodent models.

Authors:  Gretchen M Sprow; Todd E Thiele
Journal:  Physiol Behav       Date:  2012-01-08

Review 3.  Shared and unique mechanisms underlying binge eating disorder and addictive disorders.

Authors:  Erica M Schulte; Carlos M Grilo; Ashley N Gearhardt
Journal:  Clin Psychol Rev       Date:  2016-02-04

Review 4.  Applications of schedule-induced polydipsia in rodents for the study of an excessive ethanol intake phenotype.

Authors:  Matthew M Ford
Journal:  Alcohol       Date:  2014-02-28       Impact factor: 2.405

5.  Differential potassium channel gene regulation in BXD mice reveals novel targets for pharmacogenetic therapies to reduce heavy alcohol drinking.

Authors:  Jennifer A Rinker; Diana B Fulmer; Heather Trantham-Davidson; Maren L Smith; Robert W Williams; Marcelo F Lopez; Patrick K Randall; L Judson Chandler; Michael F Miles; Howard C Becker; Patrick J Mulholland
Journal:  Alcohol       Date:  2016-06-27       Impact factor: 2.405

6.  mTORC1 pathway is involved in the kappa opioid receptor activation-induced increase in excessive alcohol drinking in mice.

Authors:  Yan Zhou; Yupu Liang; Mary Jeanne Kreek
Journal:  Pharmacol Biochem Behav       Date:  2020-05-26       Impact factor: 3.533

7.  Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Authors:  Eric W Fish; Abigail E Agoglia; Michael C Krouse; R Grant Muller; J Elliott Robinson; C J Malanga
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

8.  Animal models of excessive alcohol consumption: recent advances and future challenges.

Authors:  Howard C Becker; Dorit Ron
Journal:  Alcohol       Date:  2014-04-08       Impact factor: 2.405

9.  Novel anticonvulsants for reducing alcohol consumption: A review of evidence from preclinical rodent drinking models.

Authors:  A E Padula; N S McGuier; W C Griffin; M F Lopez; H C Becker; P J Mulholland
Journal:  OA Alcohol       Date:  2013-02-01

10.  Social stress-escalated intermittent alcohol drinking: modulation by CRF-R1 in the ventral tegmental area and accumbal dopamine in mice.

Authors:  Lara S Hwa; Elizabeth N Holly; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-11-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.